Stopping Treatment — How Families Reach the Decision

Families decide together, not alone. The oncologist explains what continuing is likely to offer and what it will cost in side effects, time and money. The patient says what matters most to them now. The family listens, asks questions, and agrees a plan — including a date to review it.

This page will not tell you to stop, and it will not tell you to continue. Both are real, respected choices. What follows is how the conversation is usually structured, who belongs in it, and which questions make it easier.

Oncology teams call this a goals-of-care conversation. It is not a single yes-or-no moment. It is a discussion about what you are trying to achieve now — more time, fewer hospital visits, better sleep, a wedding in the family, being at home — and which plan fits that best. Treatment decisions follow from those goals, not the other way round.

Only your treating oncologist, looking at your own scans and reports, can say what continuing would realistically mean in your case. Nothing here is a signal to stop, or a prediction about what will happen either way.

Continuing treatment as planned is a valid answer too — for many families it is the right one.

No. Stopping disease-directed treatment ends one part of care, not the whole of it. Symptom control, pain and breathlessness management, nutrition support, counselling and regular review all continue. Many families are surprised by how much active support is still available once the word “stop” has been said out loud.

At CION, immunotherapy is given as a day-care treatment, and the supportive services around it — medical oncology review, nutrition, psycho-oncology, pain and symptom management — are part of the same service, not a separate department you are handed over to. Palliative care alongside immunotherapy explains how the two run in parallel rather than in sequence.

Before you leave the hospital, ask for the next few weeks in writing: who will see you, how often, which number to call between visits, and what should prompt an unscheduled call. That written plan is reasonable to ask for and should be given.

Questions for the oncologist

• “What is continuing likely to achieve in our case?” — ask for an answer based on your own scans and reports, not on general statistics.
• “What would change immediately if we stopped?” — monitoring, follow-up frequency, medicines, and what to watch for in the first few weeks.
• “What care continues either way?” — pain and symptom control, nutrition, counselling and review are rarely spelled out unless you ask.
• “Can we set a date to review this?” — a pause with a review date is a different decision from stopping for good. Ask which one is on the table.

Questions for each other

• “What does the patient actually want?” — asked directly, and answered by the patient, not on their behalf.
• “What is each of us afraid of?” — fear of regret, fear of pain, fear of money running out. Naming it stops it driving the decision unseen.
• “What would we regret in six months?” — families answer this more honestly than they answer “what should we do?”.

Disagreement is common and it is not a failure. It usually takes one of three shapes: the patient is ready to stop while a son or daughter wants to keep going, one relative believes a different hospital would offer more, or the real argument is about money and no one has said so.

Where the split is about money, name it plainly — cost is a legitimate input into a treatment decision, not a moral failing. When the Money Runs Out Before the Treatment Does deals with that situation directly, including scheme cover and what to ask the hospital about. Where the split is about whether the treatment is still working, ask the oncologist to explain what the scans show; why immunotherapy stops working covers what acquired resistance means in practice.

Where a patient wants to stop and the family does not, the team can help — see when the patient wants to stop and the family does not. Ask for a second family meeting rather than settling it over phone calls between relatives, and consider asking a palliative-care specialist or counsellor to sit in.

• If cost is the pressure behind the conversation, When the Money Runs Out Before the Treatment Does covers what to ask about scheme cover and how to raise it with the team.
• If the treatment worked and then stopped working, Why Does Immunotherapy Stop Working? Acquired Resistance explains what that means and what usually happens next.
• If it never seemed to work at all, Primary Resistance: When It Never Worked at All explains why that happens for some patients from the start.
• For the full picture of how the treatment is given, monitored and reviewed, see Immunotherapy at CION Cancer Clinics.

This page is general patient-education information written to support a family conversation. It is not a recommendation to stop or to continue treatment, and it is not a substitute for the guidance your own oncology team gives you based on your diagnosis, your scans and your treatment history.

Whatever You Decide, Decide With Full Information

A medical oncologist can walk your family through the realistic benefit, the burden, and what continues either way — so the decision, in either direction, is genuinely informed.

This page is general patient-education information written to support a family conversation, not a recommendation to stop or continue treatment. Your own oncology team is the only source of guidance for your specific diagnosis and treatment plan.